Initial Dutton Report had a price target of $1.50..

SUMMARY

Patriot Scientifics common stock continues to trade in a range of a $0.44 low to a $0.72 high per share. Patriot Scientifics dividend declaration of $0.02 on February 23, 2007 (to shareholders of record as of March 6, 2007, and payable April 9, 2007), was mostly ignored by investors. We cannot stress enough, with the continued announcements of additional licensees, that we strongly believe that investors should seriously review Patriot Scientifics fundamental revenue and earnings potential. The 15 licenses granted thus far are just scratching the surface of the potential 400, and not only are these additional licenses a plus for current revenue and earnings, but the granted licenses give validity to the patents that are the subject of an infringement litigation that is pending in Texas against defendants Matsushita (NYSE:MC-$19.20) and Toshiba Corp. (OTCPK:TOSBF-$5.95).  We reiterate our Strong Speculative Buy rating and maintain our 12-month price target of $1.50.

Now with what even Dutton speculates appears to be a favorable Markman ruling their target price is now $0.75.. in 12 months... ?

If Dutton is so worried about the USPTO, stop covering the stock until that is resolved, two yrs from now... please.